What is enclomiphene?

Enclomiphene is the more biologically active form of clomiphene citrate, a selective estrogen receptor modulator (SERM) that works by blocking estrogen's feedback signals to the pituitary gland. By preventing estrogen from suppressing luteinizing hormone (LH) and follicle-stimulating hormone (FSH), enclomiphene prompts the body to increase its own testosterone production rather than introducing synthetic testosterone directly.

Unlike traditional testosterone replacement therapy (TRT), which delivers exogenous hormones, enclomiphene preserves the body's natural endocrine function and maintains testicular volume and fertility potential. This distinction matters for men concerned about long-term hormonal dependency or who wish to retain reproductive capacity. The therapy appeals to patients seeking to optimize testosterone levels while keeping their body's signaling pathways active.

Regulatory status varies by jurisdiction. In the United States, clomiphene citrate carries FDA approval for treating female infertility, but its use for male testosterone support remains off-label. Florida hormone therapy clinics operate under state medical board oversight, and prescribing enclomiphene requires a physician's clinical judgment and appropriate patient evaluation. Some practitioners favor it as an alternative to traditional TRT protocols, particularly in cases where preserving natural testosterone production is a priority.